Invention Grant
- Patent Title: Spiro bicyclic inhibitors of menin-MLL interaction
-
Application No.: US17536899Application Date: 2021-11-29
-
Publication No.: US12084462B2Publication Date: 2024-09-10
- Inventor: Patrick Rene Angibaud , Vineet Pande , Barbara Herkert , Daniel Jason Krosky , Olivier Alexis Georges Querolle , Aaron Nathaniel Patrick , Isabelle Noelle Constance Pilatte
- Applicant: Janssen Pharmaceutica NV
- Applicant Address: BE Beerse
- Assignee: Janssen Pharmaceutica NV
- Current Assignee: Janssen Pharmaceutica NV
- Current Assignee Address: BE Beerse
- Agency: BakerHostetler
- Main IPC: C07D519/00
- IPC: C07D519/00 ; A61P35/00 ; A61P35/02
Abstract:
The present invention relates to pharmaceutical agents useful for therapy and/or prophylaxis in a mammal, and in particular to spiro bicyclic compounds, pharmaceutical composition comprising such compounds, and their use as menin/MLL protein/protein interaction inhibitors, useful for treating diseases such as cancer, myelodysplastic syndrome (MDS) and diabetes.
Public/Granted literature
- US20220227786A1 Spiro Bicyclic Inhibitors Of Menin-MLL Interaction Public/Granted day:2022-07-21
Information query
